References
Urinary Incontinence in Adults Guideline Update Panel. Urinary incontinence in adults: acute and chronic management. US Dept Health Human Serv AHCPR 1996; 2: 1–51
Owens RG, Karram MM. Comparative tolerability of drug therapies used to treat incontinence and enuresis. Drug Saf 1998 Aug; 19(2): 123–39
Coombes GM, Millard RJ. Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline. Med J Aust 1996; 165: 473–6
Muskat Y, Bukovsky I, Shneider D, et al. The use of scopolamine in the treatment of detrusor instability. J Urol 1996; 156: 1989–90
Lose G, Jorgensen L, Thunedborg P. Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study. J Urol 1989; 142: 1024–6
Cardozo L, Stanton SL, Robinson H, et al. Evaluation of flurbiprofen in detrusor instability. BMJ 1980; 2: 281–2
Palmer JH, Worth PHL, Exton-Smith AN. Flunarizine: a once-daily therapy for urinary incontinence. Lancet 1981; 8: 279–81
Fantl JA, Cardozo L, McClish D, et al. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of hormones and urogenital therapy committee. Obstet Gynecol 1994 Jan; 83: 12–8
Hilton P, Tweddell AL, Mayne C. Oral and intravaginal estrogens alone and in combination with alpha-adrenergic stimulation in genuine stress incontinence. Int Urogynecol J 1990; 1: 80–6
Rights and permissions
About this article
Cite this article
Treatment of incontinence less than ideal. Drugs Ther. Perspect 13, 13–16 (1999). https://doi.org/10.2165/00042310-199913120-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199913120-00005